ERBB2 and breast cancer: Exposure of luminal (MCF7), triple-negative (MDA-MB-231) and HER2+ (BT474) breast cancer cells to a relatively low dose of GA (10 μM) reduced the overall protein SUMOylation in these cells by ∼40–50% (Fig. 1A).